Supplements and compounds that support joint mobility, cartilage health, and connective tissue integrity.
23 itemsAnimal studies suggest BPC-157 may support tendon, ligament, and muscle repair via angiogenesis and anti-inflammatory pathways, but human trials are lacking and it’s prohibited in sport.
Vitamin C’s underrated role as a collagen cofactor—what science says about skin aging, wound healing, and tendon support, plus insights from traditional vitamin C–rich foods.
Animal research suggests BPC-157 may support tendon and ligament repair via angiogenesis and anti-inflammatory pathways, but human RCTs are lacking and the peptide is not approved for medical use.
Vitamin C’s role in collagen synthesis—how it may support skin elasticity, tendon integrity, and wound healing, plus traditional sources like amla, acerola, and camu camu.
Animal studies suggest BPC‑157 may influence tendon and ligament healing via angiogenesis and fibroblast pathways, but no human trials confirm benefit. Not approved for medical use and prohibited by WADA.
Vitamin C’s most vital job may be powering collagen synthesis. Learn how it supports skin, gums, tendons, and wound repair—what’s proven, what’s promising, and how traditional sources like amla fit in.
Animal studies suggest BPC-157 may support tendon and ligament healing via angiogenesis and ECM remodeling, but robust human trials are lacking; it remains unapproved and is banned by WADA.
A focused, evidence-based look at vitamin C’s essential role as a collagen cofactor, what clinical studies show for skin, wound healing, and connective tissue, and how traditional vitamin C–rich fruits fit in.
BPC-157 and tissue repair: what animal studies suggest about tendon and ligament healing, why athletes are curious, and the current gap in human clinical evidence and safety.
Vitamin C’s role in collagen synthesis—what research suggests for skin, wound repair, and joint health, plus delivery formats and traditional sources.
Animal research suggests BPC-157 may enhance tendon and ligament healing via angiogenesis and collagen remodeling, but human trials are lacking. Learn what the preclinical evidence shows, safety and regulatory considerations, and why athletes are interested.
A focused look at molecular mimicry—how gut microbes and infections may trigger autoimmunity—and what current evidence shows across conditions like T1D, RA, and thyroid autoimmunity.
Vitamin C’s lesser-known job: cofactor for collagen-building enzymes. Learn how this shapes skin health, joints, and wound healing, what the evidence says, and how traditional sources like amla and acerola fit in.
BPC-157 shows promising tissue repair signals in animal studies, but no peer-reviewed human trials confirm benefits. Learn the mechanisms, safety gaps, and why athletes are interested—plus anti-doping status.
Vitamin C is essential for collagen synthesis. Research suggests adequate vitamin C may support skin appearance, tendon remodeling, and wound repair—especially when combined with good iron status and appropriate loading—while traditional sources like amla, acerola, and camu camu add complementary phytochemicals.
Vitamin C’s unsung role as a collagen cofactor: what research suggests for skin integrity, wound healing, and connective tissue—plus insights on amla, acerola, and camu camu.
Vitamin C is more than a cold remedy. Explore its roles in collagen synthesis, iron absorption, neurotransmitter production, antioxidant recycling, modern debates on IV and liposomal delivery, and traditional sources like camu camu, acerola, and amla—through an evidence-based lens.
Type I, II, III — not all collagen is the same. Which forms actually work, optimal dosing, and how to pair collagen with vitamin C for absorption.
Hydrolyzed collagen protein fragments used to support skin elasticity, joint health, and connective tissue repair.
Osteoarthritis (OA) is the most common arthritis, driven by age, mechanical loading, prior injury, obesity, and genetics. It features progressive cartilage loss, subchondral bone changes, synovial activation, and periarticular muscle weakness. Patients typically report activity-related joint pain, stiffness (often <30 minutes in the morning), reduced function, and sometimes swelling or crepitus. Knees, hips, hands, and spine are most affected. Diagnosis is clinical, supported by radiographs showing joint-space narrowing, osteophytes, and sclerosis; MRI is rarely required for routine care. Western management prioritizes nonpharmacologic strategies with the strongest, most consistent benefits across guidelines: education, exercise therapy (aerobic, strengthening, neuromuscular/balance), and weight reduction for those with overweight/obesity. Topical NSAIDs are recommended as first-line pharmacologic therapy for knee and hand OA, with oral NSAIDs used when needed and appropriate. Acetaminophen has diminishing evidence of benefit. Duloxetine can help chronic OA pain, particularly knee OA. Intra-articular corticosteroid injections offer short-term relief; hyaluronic acid remains controversial with mixed evidence. Platelet-rich plasma (PRP) injections are emerging but heterogeneous and not yet guideline-endorsed broadly. Joint replacement is highly effective for end-stage disease. Eastern and traditional approaches conceptualize OA differently but often converge on movement-based and symptom-relieving therapies. In Traditional Chinese Medicine (TCM), OA commonly maps to Bi syndrome (painful obstruction) with patterns such as wind-cold-damp Bi, blood stasis, and kidney (shen) deficiency. Treatment may include acupuncture (including electroacupuncture and warm-needle techniques), moxibustion, topical herbal liniments (e.g., capsicum), tuina/manual therapy, and herbal formulas (e.g., Du Huo Ji Sheng Tang). Acupuncture for knee OA is among the best-studied TCM applications,
Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune synovitis that, without timely control, leads to pain, progressive joint damage, disability, and increased cardiovascular risk. Western medicine defines RA by characteristic clinical patterns, serologic autoantibodies, and inflammatory markers, and prioritizes early, aggressive disease modification using a treat‑to‑target strategy. This approach, guided by rigorous randomized trials and international guidelines, has transformed outcomes—many patients can now achieve low disease activity or remission and preserve function. Diagnosis in Western practice uses ACR/EULAR classification criteria that integrate joint involvement, rheumatoid factor (RF) and anti‑cyclic citrullinated peptide (anti‑CCP) antibodies, acute‑phase reactants (ESR/CRP), and symptom duration. Imaging (ultrasound/MRI) can detect subclinical synovitis and erosions early. Management begins promptly—ideally within weeks of symptom onset—because early window therapy improves long‑term trajectories. First‑line conventional synthetic disease‑modifying antirheumatic drugs (csDMARDs) include methotrexate (anchor), sulfasalazine, hydroxychloroquine, and leflunomide. If targets (remission/low disease activity) are not met, biologic DMARDs (e.g., TNF, IL‑6, T‑cell costimulation, anti‑CD20) or targeted synthetic JAK inhibitors are added or substituted, with iterative monitoring every 1–3 months and shared decision‑making. Short glucocorticoid courses are sometimes used as a bridge, while NSAIDs treat pain but do not alter disease course. Safety monitoring, vaccination, infection screening, and comorbidity risk reduction (e.g., cardiovascular prevention, bone health, smoking cessation, exercise, rehabilitation) are integral. Eastern and traditional systems conceptualize RA differently but share aims of reducing pain, swelling, and functional limitations while preventing chronic deterioration. Traditional Chinese Medicine (TCM) frames RA within “Bi” (B
Arthritis (an umbrella term that includes inflammatory types such as rheumatoid arthritis and non‑inflammatory types such as osteoarthritis) and osteoporosis frequently intersect in mid‑ to late‑li...
Psoriasis is a chronic, immune-mediated skin disease affecting roughly 2–3% of the population. Psoriatic arthritis (PsA) is an inflammatory arthropathy that occurs in a substantial subset of people...
